Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 66.56B 9.93B 8.86B 8.25B 7.51B 14.14B 956B 14.24B 99.7B 38.79B 488B 37.27B 36.46B 1,569B | P/E 2026 * |
50.2x | P/E 2027 * | 37.9x |
|---|---|---|---|---|---|
| Enterprise Value | 61.89B 9.23B 8.23B 7.67B 6.98B 13.15B 889B 13.24B 92.7B 36.07B 454B 34.65B 33.9B 1,458B | EV / Sales 2026 * |
7.65x | EV / Sales 2027 * | 6.42x |
| Free-Float |
62.13% | Yield 2026 * |
0.72% | Yield 2027 * | 0.96% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 1998-10-06 |
Rui Yang
CEO | Chief Executive Officer | 49 | 2022-01-18 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 2011-07-17 |
Hao Hong
CHM | Chairman | 70 | 1998-10-06 |
Ye Song
BRD | Director/Board Member | 65 | 2011-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 9.93B | ||
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | ||
| -1.21% | -6.99% | +34.08% | +60.96% | 617B | ||
| +1.12% | -0.20% | +13.62% | +80.24% | 464B | ||
| -3.30% | -6.15% | +56.45% | +34.69% | 356B | ||
| +0.93% | -1.83% | +21.65% | +41.43% | 333B | ||
| +0.12% | -4.05% | +10.70% | +33.53% | 267B | ||
| -0.89% | -5.83% | -7.00% | +7.91% | 244B | ||
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | ||
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | ||
| Average | +0.19% | -3.74% | +25.47% | +57.28% | 410.8B | |
| Weighted average by Cap. | +0.44% | -3.63% | +28.50% | +68.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.08B 1.21B 1.08B 1B 912M 1.72B 116B 1.73B 12.11B 4.71B 59.27B 4.53B 4.43B 191B | 9.68B 1.44B 1.29B 1.2B 1.09B 2.06B 139B 2.07B 14.5B 5.64B 70.95B 5.42B 5.3B 228B |
| Net income | 1.35B 202M 180M 168M 152M 287M 19.41B 289M 2.02B 788M 9.91B 757M 740M 31.85B | 1.79B 268M 239M 223M 202M 381M 25.78B 384M 2.69B 1.05B 13.16B 1.01B 983M 42.3B |
| Net Debt | -4.67B -697M -622M -579M -527M -993M -67.13B -1B -7B -2.72B -34.26B -2.62B -2.56B -110B | -3.66B -545M -486M -453M -412M -777M -52.51B -782M -5.48B -2.13B -26.8B -2.05B -2B -86.15B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















